Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related TEVA
Does Teva Pharmaceutical's New Executive Hint At A Coming M&A Deal?
Morning Market Gainers
Bernstein raises Teva price target; company eyeing acquistions (Seeking Alpha)
Related JASO
Credit Suisse Expects Strong Growth In 2015 For JA Solar
Solar Stocks To Watch Following JA Solar's Q4 Report
Busting The Myth Of Grid Parity: Why Grid Parity Is A Misused Concept In U.S. Solar - Part II (Seeking Alpha)

Analysts at Morgan Stanley upgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “underweight” to “equal-weight.” The price target for Teva Pharmaceutical is set to $52. Teva Pharmaceutical's shares closed at $47.96 yesterday.

Axiom upgraded JA Solar Holdings Co (NASDAQ: JASO) from “undefined” to “buy.” The price target for JA Solar is set to $16. JA Solar's shares closed at $10.55 yesterday.

Analysts at Keefe Bruyette & Woods upgraded Independent Bank (NASDAQ: INDB) from “market perform” to “outperform.” The price target for Independent Bank has been raised from $40 to $44. Independent Bank's shares closed at $38.11 yesterday.

Oppenheimer upgraded Lowe's Companies (NYSE: LOW) from “market perform” to “outperform.” The price target for Lowe's Companies has been raised from $50 to $57. Lowe's shares closed at $48.71 yesterday.

Latest Ratings for TEVA

DateFirmActionFromTo
Mar 2015Standpoint Research
Mar 2015JP MorganMaintainsNeutral
Mar 2015Leerink SwannMaintainsOutperform

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (INDB + JASO)

Around the Web, We're Loving...